Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143396 |
| CAS No | NA |
| Mol.F. | C15H22N2O5 |
| Mol.Wt. | 310.4 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143397 |
| CAS No | NA |
| Mol.F. | C18H29N3O4 |
| Mol.Wt. | 351.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143398 |
| CAS No | NA |
| Mol.F. | C6H13ClN2O2 |
| Mol.Wt. | 180.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143399 |
| CAS No | NA |
| Mol.F. | C6H12N2O2 |
| Mol.Wt. | 144.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143400 |
| CAS No | NA |
| Mol.F. | C18H17F3N2O3 |
| Mol.Wt. | 398.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143401 |
| CAS No | NA |
| Mol.F. | C32H25F6N3O6 |
| Mol.Wt. | 661.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143402 |
| CAS No | NA |
| Mol.F. | C17H24N6O3 |
| Mol.Wt. | 360.4 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143403 |
| CAS No | NA |
| Mol.F. | C10H13N3O2 |
| Mol.Wt. | 207.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143404 |
| CAS No | NA |
| Mol.F. | C7H8N2O3 |
| Mol.Wt. | 168.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143405 |
| CAS No | NA |
| Mol.F. | C24H26F2N6O3 |
| Mol.Wt. | 484.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143406 |
| CAS No | NA |
| Mol.F. | C24H20N4O4 |
| Mol.Wt. | 428.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143407 |
| CAS No | NA |
| Mol.F. | C33H34N6O6 |
| Mol.Wt. | 610.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143408 |
| CAS No | NA |
| Mol.F. | C32H34N6O5 |
| Mol.Wt. | 582.66g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143409 |
| CAS No | NA |
| Mol.F. | C27H26F2N6O4 |
| Mol.Wt. | 536.54 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143410 |
| CAS No | NA |
| Mol.F. | C23H28N4O5S |
| Mol.Wt. | 472.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143411 |
| CAS No | NA |
| Mol.F. | C23H22F2N6O3 |
| Mol.Wt. | 468.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |